PreveCeutical Medical

(OTC) PRVCF

Current Price$0.02

Market Cap$9.33M

Since IPO (2017)-87%

5 Year-31%

1 Year-22%

1 Month+14%

PreveCeutical Medical Financials at a Glance

Market Cap

$9.33M

Revenue (TTM)

$0.00

Net Income (TTM)

$3.08M

EPS (TTM)

$-0.00

P/E Ratio

-4.08

Dividend

$0.00

Beta (Volatility)

0.08 (Low)

Dividend

$0.00

Beta (Volatility)

0.08 (Low)

Price

$0.02

Volume

2,225

Open

$0.02

Price

$0.02

Volume

2,225

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.00 - $0.04

Dividend

$0.00

Beta (Volatility)

0.08 (Low)

Price

$0.02

Volume

2,225

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.00 - $0.04

PRVCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PreveCeutical Medical

Industry

Pharmaceuticals

Sector

Health Care

CEO

Stephen van Deventer

Website

www.preveceutical.com

Headquarters

Vancouver, BC V6B 0R6, CA

PRVCF Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

38%

Return on Assets

-7%

Earnings Yield

-24.51%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.33M

Shares Outstanding

586.81M

Volume

2.23K

Avg. Volume

42.37K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$812.47K

EBITDA

$752.58K

Operating Cash Flow

$426.69K

Capital Expenditure

$1.80K

Free Cash Flow

$428.49K

Cash & ST Invst.

$59.14K

Total Debt

$4.46M

PreveCeutical Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$3.61K

N/A

Gross Margin

0.00%

N/A

Market Cap

$9.33M

N/A

Market Cap/Employee

$1.33M

N/A

Employees

N/A

Net Income

$818.92K

-143.7%

EBITDA

$769.24K

-206.5%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Net Cash

$4.50M

-4.7%

Accounts Receivable

$18.83K

-27.3%

Inventory

$0.00

N/A

Long Term Debt

$65.19K

+5.0%

Short Term Debt

$4.54M

+7.1%

Return on Assets

-6.75%

N/A

Return on Invested Capital

38.19%

N/A

Free Cash Flow

$521.20K

-365.8%

Operating Cash Flow

$521.19K

-366.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IMUCEOM Pharmaceuticals Holdings, Inc.

IMUCEOM Pharmaceuticals Holdings, Inc.$0.09+0.00%

ZHCLFZenith Capital Corp.

ZHCLFZenith Capital Corp.$0.06+0.00%

SRBCFSirona Biochem Corp.

SRBCFSirona Biochem Corp.$0.01+0.00%

PPCBPropanc Biopharma, Inc.

PPCBPropanc Biopharma, Inc.$0.10+1.67%

SYGGFSynairgen plc

SYGGFSynairgen plc$0.00+0.00%

TELIFTelescope Innovations Corp.

TELIFTelescope Innovations Corp.$0.35+1.11%

CLCSCell Source, Inc.

CLCSCell Source, Inc.$0.84+2.74%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

TSLATesla

TSLATesla$390.82+0.02%

NIONio

NIONio$5.91-0.08%

Questions About PRVCF

What is the current price of PreveCeutical Medical?

PreveCeutical Medical is trading at $0.02 per share.

What is the 52-week range for PreveCeutical Medical?

Over the past 52 weeks, PreveCeutical Medical has traded between $0.00 and $0.04.

How much debt does PreveCeutical Medical have?

As of the most recent reporting period, PreveCeutical Medical reported total debt of $3.30M.

How much cash does PreveCeutical Medical have on hand?

PreveCeutical Medical reported $74,512.721 in cash and cash equivalents in its most recent financial results.

What is PreveCeutical Medical’s dividend yield?

PreveCeutical Medical does not currently have a dividend yield.

PreveCeutical Medical

PreveCeutical Medical Financials at a Glance

PRVCF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About PreveCeutical Medical

PRVCF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

PreveCeutical Medical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PRVCF

What is the current price of PreveCeutical Medical?

What is the 52-week range for PreveCeutical Medical?

How much debt does PreveCeutical Medical have?

How much cash does PreveCeutical Medical have on hand?

What is PreveCeutical Medical’s dividend yield?

Premium Investing Services